Maternity

Revvity to Present at Upcoming Investor Conferences

Retrieved on: 
Wednesday, February 21, 2024

Attendees will receive an update on the Company and its strategic priorities.

Key Points: 
  • Attendees will receive an update on the Company and its strategic priorities.
  • Live audio webcasts will be available on the Events section of the Company’s website.
  • Replays of the presentations will be posted on the Revvity Investor Relations website after the events and will be available for at least 30 days.

AngelEye Unveils Major Enhancements in NICU Family Engagement with Upgraded Platform

Retrieved on: 
Wednesday, February 21, 2024

AngelEye Health , the leading technology provider for neonatal and pediatric family engagement services, is announcing Version 5 of its platform, delivering a major advancement to its family and clinical engagement portal.

Key Points: 
  • AngelEye Health , the leading technology provider for neonatal and pediatric family engagement services, is announcing Version 5 of its platform, delivering a major advancement to its family and clinical engagement portal.
  • The updated engagement portal serves as a centralized hub to connect parents with their infants and caregivers.
  • The Version 5 upgrade:
    "While our NICU engagement technology has been continually updated over the last several years, we knew it was time for a leap forward," said Christopher Rand, chief executive officer at AngelEye.
  • Version 5 will be the standard platform for new customers, offering the latest technology in NICU communication and engagement.

Pediatrix Medical Group Reports Fourth Quarter Results

Retrieved on: 
Tuesday, February 20, 2024

For the fourth quarter of 2023, transformational and restructuring related expenses totaled $2.2 million, compared to $19.6 million for the fourth quarter of 2022.

Key Points: 
  • For the fourth quarter of 2023, transformational and restructuring related expenses totaled $2.2 million, compared to $19.6 million for the fourth quarter of 2022.
  • Depreciation and amortization expense of $9.1 million for the fourth quarter of 2023 was unchanged compared to the fourth quarter of 2022.
  • For the fourth quarter of 2023, Pediatrix reported Adjusted EPS from continuing operations of $0.32, compared to $0.47 for the fourth quarter of 2022.
  • For the fourth quarter of 2023, Pediatrix generated cash from continuing operations of $72.1 million, compared to $102.3 million for the fourth quarter of 2022.

San Diego Fertility Center, an Ivy Fertility Clinic, Hires Dr. Valerie Flores

Retrieved on: 
Wednesday, February 21, 2024

Ivy Fertility, a collaborative network of globally-renowned fertility clinics, has welcomed Valerie Flores, MD to its team of physicians at San Diego Fertility Center (SDFC).

Key Points: 
  • Ivy Fertility, a collaborative network of globally-renowned fertility clinics, has welcomed Valerie Flores, MD to its team of physicians at San Diego Fertility Center (SDFC).
  • “We are thrilled that Dr. Flores will be contributing her talents to our physician team,” said Sandy Chuan, MD, medical director at San Diego Fertility Center.
  • She comes to San Diego Fertility Center from Reproductive Partners Fertility Center in San Diego, is an Assistant Professor Adjunct at Yale University’s School of Medicine.
  • “I admire San Diego Fertility Center and Ivy Fertility for leading our industry by putting compassion and collaboration first,” said Dr. Flores.

Carter’s, Inc. to Report Fourth Quarter and Fiscal Year 2023 Results on Tuesday, February 27, 2024

Retrieved on: 
Tuesday, February 20, 2024

Carter’s, Inc. (NYSE:CRI), the largest branded marketer in North America of apparel exclusively for babies and young children, will report its fourth quarter and fiscal year 2023 results before the market opens on Tuesday, February 27, 2024.

Key Points: 
  • Carter’s, Inc. (NYSE:CRI), the largest branded marketer in North America of apparel exclusively for babies and young children, will report its fourth quarter and fiscal year 2023 results before the market opens on Tuesday, February 27, 2024.
  • The Company will host a conference call to discuss its results and business outlook on this date at 8:30 a.m. Eastern Standard Time.
  • To listen to a live webcast and view the accompanying presentation materials, please visit ir.carters.com and select links for “News & Events” followed by “Webcasts & Presentations.”
    To access the call by phone, please preregister via the following link to receive your dial-in number and unique passcode: https://register.vevent.com/register/BIaee6e086e7574b0db4355d2c2a89c065 .

Pediatric Nutrition Company Bobbie Launches Organic Infant Supplements, Expanding Current Product Line

Retrieved on: 
Monday, February 19, 2024

Bobbie, the mom-founded pediatric nutrition company, today announced its first move beyond infant formula with two organic infant supplements: Vitamin D and Probiotic Drops.

Key Points: 
  • Bobbie, the mom-founded pediatric nutrition company, today announced its first move beyond infant formula with two organic infant supplements: Vitamin D and Probiotic Drops.
  • View the full release here: https://www.businesswire.com/news/home/20240219495444/en/
    The new Bobbie product suite, including organic infant boosters.
  • (Photo: Business Wire)
    Consistent with Bobbie’s mission, philosophy, and product vision, these infant supplements were developed with the knowledge that every feeding journey is unique and ever-evolving.
  • Introducing Bobbie Organic Vitamin D Drops and Organic Probiotic Drops: both infant and toddler supplements are made with certified organic ingredients that are non-GMO, GRAS, and vegan.

Mercedes-Benz USA Collaborates with Children’s Healthcare of Atlanta for “Week of Caring”

Retrieved on: 
Friday, February 16, 2024

Yesterday, Mercedes-Benz USA (MBUSA) concluded their “Week of Caring” with Children's Healthcare of Atlanta (Children’s) to bring comfort and joy to patients and their families.

Key Points: 
  • Yesterday, Mercedes-Benz USA (MBUSA) concluded their “Week of Caring” with Children's Healthcare of Atlanta (Children’s) to bring comfort and joy to patients and their families.
  • “Week of Caring” served as the MBUSA employee kick-off event to celebrate the recently announced multi-year partnership with Children’s Healthcare of Atlanta, specifically through the support of Arthur M. Blank Hospital.
  • MBUSA is pleased to support a unique opportunity to provide new possibilities for generations of children to come.
  • For more information on Children’s Healthcare of Atlanta, please visit https://www.choa.org/ .

Ahma & Co Announces Launch of First Postnatal Retreat at Waldorf Astoria Monarch Beach

Retrieved on: 
Thursday, February 15, 2024

Ahma & Co , a postnatal retreat providing holistic postpartum recovery and newborn care support for mothers in the crucial first weeks, today announced the opening of its first-ever retreat at Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA, set to welcome new mothers beginning March 15, 2024.

Key Points: 
  • Ahma & Co , a postnatal retreat providing holistic postpartum recovery and newborn care support for mothers in the crucial first weeks, today announced the opening of its first-ever retreat at Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA, set to welcome new mothers beginning March 15, 2024.
  • An exclusive offer for March bookings is available at $1,400 starting price per night to celebrate this monumental opening.
  • With a minimum stay of 3 nights, Ahma & Co welcomes mothers up to 6 weeks postpartum, with opportunity to coordinate continued care past the retreat stay.
  • Ahma & Co is more than a retreat; it’s a movement towards a future where every mother can access the care they need to thrive, in postpartum and beyond.

Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution)

Retrieved on: 
Thursday, February 15, 2024

Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, announced today the positive outcome of the Decentralised Procedure (DCP) for VIGZIP™ (vigabatrin oral solution) in Europe.

Key Points: 
  • Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, announced today the positive outcome of the Decentralised Procedure (DCP) for VIGZIP™ (vigabatrin oral solution) in Europe.
  • "We are incredibly pleased with the positive outcome supporting the approval of VIGZIP™ in several key European markets.
  • This achievement serves as a testament to our dedication to developing innovative solutions for unmet medical needs in rare pediatric diseases.
  • Pyros remains committed to expanding access to VIGZIP™ in other additional territories around the world,” stated Michael Smith, Chief Executive Officer of Pyros.

Internist Shirin Peters, M.D. of Bethany Medical Clinic, Shares Top Tips for the Challenges of Winter Allergies

Retrieved on: 
Thursday, February 15, 2024

has identified at-home recommendations to combat winter allergy symptoms, helping allergy sufferers manage triggers, ease concerns, and avoid future flare-ups.

Key Points: 
  • has identified at-home recommendations to combat winter allergy symptoms, helping allergy sufferers manage triggers, ease concerns, and avoid future flare-ups.
  • “Many associate seasonal allergies just with spring but winter presents a different challenge to allergy sufferers.
  • Moreover, simple lifestyle changes and at-home tips can help manage symptoms and bring some relief during these cooler months,” says Dr. Peters, with Bethany Medical Clinic.
  • Dr. Peters shares preventative measures to decrease your chances of winter and indoor allergies and lower your risk of developing sinusitis and nasal polyps.